Abstract
Addition of Cyclophosphamide and Higher Doses of Dexamethasone Do Not Improve Outcomes of Patients With AL amyloidosis Treated With Bortezomib
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have